Total Funding
34
74
Total FundingGrant raised
Growth Score 34 in past quarter
-4 pts
Heat Score 74 in past quarter
-13 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
182328
Aurora Oncology provides new diagnostic and treatment approaches for cancer patients.
Richard C. Duke: Chairman & Acting CEOPast Role: PeptiVir, Chairman- Michael Glode: Founder and President
About the Company
Aurora Oncology is an early clinical-stage biopharmaceutical company developing targeted therapeutics to image and treat non-muscle invasive bladder cancer, the most common and insidious form of bladder cancer.